BOSTON – Following the Senate Health, Education, Labor and Pensions Committee's overwhelming approval to reauthorize the Pandemic and All Hazards Preparedness Act, which is set to expire in September, the House starts to examine renewal options for health emergency preparedness programs this week. It helps fund U.S. response to future threats and beef up the nation's medical countermeasure enterprise. But ultimately, some of the projects its funds flow to also support civilian biopharma ventures.